Getting in shape isn’t just a numbers game. Experts share how strategically timing your workouts and listening to your body will give you the edge.

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

With the rise in the use of weight loss medications, new questions are emerging about where the body positivity movement fits ...

Insurers said they had to withdraw coverage because the pricey medicines overwhelmed their budgets, forcing patients to either go off the drugs or pay for them out of pocket.

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Weight loss drugs like Ozempic, Wegovy and Mounjaro have given millions of people hope. But scammers are cashing in — and experts say it could be ...

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...

Airlines could have weight loss drug manufacturers to thank for savings if passengers become lighter, allowing carriers to spend less money on fuel. As GLP-1 medications for weight loss become ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight. By Dani Blum Weight-loss drugs like ...